Mesa Laboratories (NASDAQ:MLAB) Posts Earnings Results, Beats Estimates By $0.66 EPS

Mesa Laboratories (NASDAQ:MLAB) issued its earnings results on Tuesday. The medical instruments supplier reported $3.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.41 by $0.66, FiscalAI reports. The firm had revenue of $65.13 million for the quarter, compared to analysts’ expectations of $63.23 million. Mesa Laboratories had a positive return on equity of 21.59% and a negative net margin of 0.64%.

Mesa Laboratories Stock Performance

MLAB stock opened at $80.50 on Tuesday. The firm has a market cap of $444.36 million, a price-to-earnings ratio of -251.56 and a beta of 0.89. Mesa Laboratories has a twelve month low of $55.45 and a twelve month high of $155.12. The company has a quick ratio of 1.44, a current ratio of 2.02 and a debt-to-equity ratio of 0.95. The business’s fifty day simple moving average is $81.28 and its two-hundred day simple moving average is $74.37.

Mesa Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Saturday, February 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, February 27th. This represents a $0.64 dividend on an annualized basis and a yield of 0.8%. Mesa Laboratories’s payout ratio is presently -200.00%.

Institutional Trading of Mesa Laboratories

A number of large investors have recently modified their holdings of MLAB. Boston Partners raised its position in Mesa Laboratories by 2,009.5% during the 3rd quarter. Boston Partners now owns 114,357 shares of the medical instruments supplier’s stock valued at $7,664,000 after purchasing an additional 108,936 shares in the last quarter. Millennium Management LLC raised its holdings in Mesa Laboratories by 131.9% in the third quarter. Millennium Management LLC now owns 133,817 shares of the medical instruments supplier’s stock worth $8,967,000 after purchasing an additional 76,107 shares in the last quarter. Kennedy Capital Management LLC boosted its stake in Mesa Laboratories by 34.3% in the third quarter. Kennedy Capital Management LLC now owns 121,546 shares of the medical instruments supplier’s stock valued at $8,145,000 after acquiring an additional 31,067 shares in the last quarter. Select Equity Group L.P. grew its stake in Mesa Laboratories by 38.3% during the 2nd quarter. Select Equity Group L.P. now owns 102,198 shares of the medical instruments supplier’s stock worth $9,629,000 after buying an additional 28,301 shares during the last quarter. Finally, Gabelli Funds LLC purchased a new stake in shares of Mesa Laboratories during the second quarter worth about $2,370,000. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on MLAB shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Mesa Laboratories in a research note on Thursday, January 22nd. Wells Fargo & Company raised their target price on shares of Mesa Laboratories from $75.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Wall Street Zen raised shares of Mesa Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, November 8th. Finally, Zacks Research upgraded shares of Mesa Laboratories from a “strong sell” rating to a “hold” rating in a report on Friday, January 9th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $83.00.

About Mesa Laboratories

Mesa Laboratories, Inc (NASDAQ: MLAB) is a global provider of instrumentation products designed for critical process monitoring, testing and calibration. Headquartered in Lakewood, Colorado, the company serves a diverse set of end markets including healthcare, pharmaceutical, food and beverage, energy and industrial sectors. With a focus on precision measurement and validation, Mesa Laboratories helps customers ensure regulatory compliance, product safety and operational efficiency across complex manufacturing and sterilization processes.

The company’s product portfolio encompasses biological and chemical indicators for sterilization process validation, digital data loggers and sensors for environmental monitoring, and optical gas analyzers with sample-conditioning solutions for oil, gas and petrochemical applications.